Neuromyelitis optica (NMOSD): vizsgálatok itt: Kína
34 trials · From ClinicalTrials.gov, checked 2026. november 17.. Ask the study team whether a trial fits you.
- Korai 1. fázisTaking peopleUniversal Chimeric Antigen Receptor T-Cell (UCAR T-cell) Therapy Targeting CD19/B Cell Maturation Antigen (CD19/BCMA) in Patients With r/r Neurological Autoimmune Diseases
- Where
- Tianjin
- Életkor
- 18 év and over
- People
- 12
- Run by
- Tianjin Huanhu Hospital
See details and how to joinNCT06939166 - No phaseTaking peopleMonoclonal Antibody-Based Therapies for AQP4-Positive NMOSD
- Where
- Wuhan
- Életkor
- 18 év to 65 év
- People
- 200
- Run by
- Tongji Hospital
See details and how to joinNCT06885957 - 1. fázisTaking peopleA Study of C-CAR168 in the Treatment of Autoimmune Diseases Refractory to Standard Therapy
- Where
- Shanghai
- Életkor
- 18 év to 70 év
- People
- 30
- Run by
- RenJi Hospital
See details and how to joinNCT06249438 - No phaseTaking peopleProtein A immuNoaDsorption for the Treatment of Acute Episodes of Neuromyelitis Optica Spectrum Disorder
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 144
- Run by
- Third Affiliated Hospital, Sun Yat-Sen University
See details and how to joinNCT06763848 - Korai 1. fázisNot yet taking people in KínaUniversal CAR-T Cells in Patients with Refractory Autoimmune Diseases of the Nervous System.
- Where
- Beijing
- Életkor
- 18 év to 75 év
- People
- 25
- Run by
- Xuanwu Hospital, Beijing
See details and how to joinNCT06485232 - 2. fázisTaking peopleA Study to Evaluate the Efficacy and Safety of JYP0061 in Patients With Acute Neuromyelitis Spectrum Disease (NMOSD)
- Where
- Changsha
- Életkor
- 18 év to 65 év
- People
- 35
- Run by
- Guangzhou JOYO Pharma Co., Ltd
See details and how to joinNCT06697535 - Korai 1. fázisTaking peopleSafety and Efficacy of CT103A Cells for Relapsed/Refractory Antibody-associated Inflammatory Diseases of the Nervous System
- Where
- Wuhan
- Életkor
- 18 év to 75 év
- People
- 36
- Run by
- Tongji Hospital
See details and how to joinNCT04561557 - No phaseTaking peopleEfficacy and Safety of Calculus Bovis Sativus (CBS) for Idiopathic Inflammatory Demyelinating Disease (CBSinIIDD)
- Where
- Wuhan
- Életkor
- 18 év and over
- People
- 250
- Run by
- Tongji Hospital
See details and how to joinNCT06474520 - No phaseTaking peopleSun Yat-Sen Cohort of CNS Idiopathic Inflammatory Demyelinating Diseases
- Where
- Guangzhou
- Életkor
- 18 év to 65 év
- People
- 450
- Run by
- Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University
See details and how to joinNCT06541626